Cullinan Therapeutics, Inc.
NASDAQ:CGEMMedical - Pharmaceuticals
Healthcare
$9.01 +4.29%
+$0.62 today
- Market cap
- $584.94M
- Beta
- 0.01
- P/E (TTM)
- -4.0
- EPS (TTM)
- -$3.73
52W Low $5.68High $16.74
Volume 1.06M
Average 0.99M
Price history
Cullinan Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+6.63%
Period high
$22.95
Period low
$8.45
Latest
$9.01
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 10, 2026 | Nov 10, 2026 | |
| SC 13G | Nov 10, 2026 | Nov 10, 2026 | |
| 8-K | Nov 10, 2026 | Nov 10, 2026 | |
| 8-K | Nov 9, 2026 | Nov 9, 2026 | |
| 4 | Nov 6, 2026 | Nov 6, 2026 | |
| 8-K | Nov 4, 2026 | Nov 4, 2026 | |
| 8-K | Oct 2, 2026 | Oct 1, 2026 | |
| 8-K | Sep 24, 2026 | Sep 24, 2026 | |
| 8-K | Sep 14, 2026 | Sep 14, 2026 | |
| 4 | Sep 10, 2026 | Sep 10, 2026 | |
| 4 | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| 8-K | Aug 13, 2026 | Aug 12, 2026 | |
| SC 13G | Aug 7, 2026 | Aug 7, 2026 |
Competitors
Who does Cullinan Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about CGEM's filings, answered from its disclosures.
What is the latest CGEM filing?
The latest filing shown is 10-Q dated Nov 10, 2026.
How many recent filings does CGEM have?
Intrinsic Alpha currently shows 20 recent filings for CGEM.
Continue the stock analysis
Jump to another research area for this company.